F10 and melanoma: To evaluate the effect of increased circulating FXa levels, Ishikawa human endometrial cancer cells were subcutaneously introduced into the flank of immunosuppressed NIH nu/nu mice and the human melanoma cell line Mel-1 into the flank of NOD/SCID mice.